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Regulation of cholecystokinin (CCK) and the proto-oncogene c-jis mRNA expression was studied in the human neuroblastoma cell line SK-N-MC. 
Cells were treated either with the Wmor promoting phorbolester phorbol-I 2-myristate-l3-acetate (PMA). the phosphodiestcrasc inhibitor isobutyl- 
methylxanthine (IBMX), which results in an elevated intracellular cyclic AMP (CAMP) level, or with a combination of PMA and IBMX. The level 
of CCK and c-Joos mRNh was dctem:ined by Northern-blo: analysis with CCK and c-fos spzcilic antisensc RNA probes after 4-24 11 of drug 
treatment. Treatment with PMA and iBMX for 4-24 hours transiently raised the CCK mRNA level -153.5 times compared to the controls, 
and the combination PMA and IBMX had an additive effect and elevated CCK mRNA abundance 1.5-6.5 times. Under the same experimental 
conditions, both PMA and IBMX elevated the c-fk mRNA level -3-5.5 times. The drug combination showed a pronounced synergistic effect 
and raised the c-j& mRNA level ~3-20 times as compared to controls. Apparently, CCK and c-fos mRNA expression appears to bc regulated 
by similar protein kinase C (PKC) and CAMP-dependent mechanisms in SK-N-MC cells. 
Cholecystokinin (CCK); C&s: Phorbol ester; CAMP: mRNA: Northern blot 
1. INTRODUCTION 
Neuropeptide gene expression in eukaryotic cells in- 
volves the induction of transcription factors which in 
term bind to specific c&-acting DNA elements sur- 
rounding the coding region of a gene [l-3]. These mech- 
anisms use signal transduction pathways common to 
many types of eukaryotic cells. Signals received at the 
cell surface regulate the production of second messen- 
gers such as CAMP and diacylglycerol which activate 
protein kinase A and C, respectively. This cascade then 
leads to the activation of (cell)-specific transcription fac- 
tors and thereby inducing expression of selected genes. 
[2/W. 
Certain proto-oncogenes such as c-fos and j[Nz are 
inducible by second messengers and the products of the 
proto-oncogenes act themselves as transcription factors 
[9-l 11. The cfis promoter contains different types of 
regulatory elements, which are essential for basal and 
stimulated c-j& mRNA expression, Two elements, re- 
sponsible for basal c-f& transcription, have been identi- 
fied and it was found that these elements resemble the 
consensus sequence of CAMP-regulated promoters (re- 
viewed in [ 10,l 11. An upstream enhancer region, located 
between -317 to -292, is required for the induction of 
the c-fos gent with e.g. serum and phorbol esters, 
C(lrrcs/~o,rt/~l/rcc trrl&css: H.-J. Monstcin, Dcparttncnt of Clinical Hio- 
chemistry. KK 3014, State University Hospital (Rigshospitalct), DK- 
2100 C~p~~,l~agcn. Dcnmurk 
Cholecystokinin (CCK) mRNA and bioactive CCK 
peptides are expressed in a cell-specific manner in the 
central nervous system, the intestinal tract, and in male 
germ cells [12-14j. Thus, several groups have investigat- 
ed clonal cell lines which express CCK at the transcrip- 
tional and translational level [ 15-211. In a recent study 
it was shown that the rat CCK gene contains a tran- 
scriptional enhancer, essential for the expression of 
CCK mRNA. Moreover, the rat CCK enhancer shows 
structural similarities with the human CCK, enkephalin 
A (PEA), and c-10,s genes, containing CAMP-(CRE) and 
phorbolester-like response elements (TRE) [ 18,221. 
In this study we describe experiments to investigate 
the effects of PMA, an activator of protein kinase C 
(PKC) and, IBMX. a phosphodiesterase inhibitor, and 
a combination of both drugs on the modulation of CCK 
and c-fiu mRNA expression in a human SK-N-MC cell 
line. 
2. MATERIALS AND METHODS 
SK-N-MC cells wcrc originally obtained from the Dept. of Patho- 
logy, Uppsala University, and maintained at the Dept. of Pharmrco- 
logy as dcscribcd carlicr [15,18]. SK-N-MC cells from passage I20 
wcrc cultured in Nunc-Pctridishcs (IOcm) at 37°C in IO ml l-I:lm’s FIO 
and Dulbcccos modilicd Eagles medium (I: I), supplcmcnted with I.56 
fetal calf strum, IO tnlll non-csscntial amino acids (Gibco. 1000 xstock 
solution), I90 rndl L-ylutaminc, and IO ml/l pcnicillin/strcptomycin 
(IO 000 U and IO OOO~g/ml) in humidilicd air containing 5% CO,. Cell 
cultures wcrc grown to a density of IO’ cells/dish and harvr-,tcd at 
appropriate times in phosphate-huffcrcd saline (I 37 mM PiaCI. 2.7 
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mM KC1 and 1.5 mM NaZHPO,-KH:,PO,; pH 7.4) supplemented with 
0.5 mM EDTA. A cell pellet was obtamed by centrifugation (I 500 x g) 
at 4°C for IO min in autoclaved Eppendorf tubes. Cells were treated 
with 0.5 mM IBMX, 0.5pM PMA or the cornbinatic.u of both drugs 
as indicated in figure legends and harvesled as above. 
2.2. Preparutiun of IOIUI RNA wd Norrhern blot mn~vsis 
Total RNA from 5 x IO’ cells was extracted according to the method 
of Chomczynski and Saechi [23]. and quantitated by UV absorption 
at 260/280 mm. Electrophoretic separation of total RNA was on a 
1.2% agarose-0.7% formaldehyde gel followed by transfer onto 
Hybond N membrane (Amersham. Birkerad. Denmark) in 25 mM 
sodium phosphate buffer (pH 6.4). Filters were fixed by UV illumina- 
tion (Stratagene. UV-box). Prior to transfer. RNA preparations were 
routinely checked for degradation by ethidium bromide striping of the 
agarose gel. 
2.3. H~bridixrion md arrrisense RNA probes (c-RNA) 
Hybridization was performed as described earlier [24]. Following 
hybridization, bands were visualized by exposure for l-3 days at 
-80°C using a DuPont intensitier screen to Fuij RXO-IG or Amer- 
sham MP films. Densitometric scanning of the Northern blots was 
carried out on a LKB-Pharmacia XL laser densitometer. The levels 
of CCK and c-/iis mRNA signals were determined relative to the 
mouse B-actin hybridization signal. 
The construction and in vitro transcription of the rat CCK and 
mouse&actin DNA templates were recently described [l5]. The c-jtis 
DNA template was purchased from Amersham. For each hybridiza- 
tion probe. -I pg plasmid DNA was in vitro transcribed either by 
RNA polymerasc SF6 or T7 using Promegas Riboprobe Kit and 50 
&i [cr-“PJUTP (400 Wmmol). 
3. RESULTS 
Phorbol-I 2-myristate- 13-acetate (PMA) a tumor pro- 
motor and potential activator of phospholipase depend- 
ent protein kinase C was used to study the effect on 
CCK and c-fos mRNA expression in SK-N-MC cells. 
To reveal possible synergistic interactions between 
protein kinase C and CAMP-dependent regulatory 
systems, treatment of SK-N-MC cells with IBMX or the 
combination PMA and IBMX was tested. Levels of 
CCK and c-fos mRNA in total RNA extracts were de- 
termined by Northern blot analysis using rat CCK and 
human c-fos antisense (cRNA) RNA hybridization 
probes. Northern blot filters initially hybridized with 
the CCK and c-j& cRNA probes, were re-probed with 
a mouse/3-actin cRNA probe, thus allowing determina- 
tion of the relative CCK and c-fos mRNA levels in each 
slot. The resul;s of these experiments are summarized 
in Fig. 1. The time course revealed that the drugs used 
had different effects on both CCK and c-j& mRNA 
expression. PMA stimulated CCK mRNA expression 
w-2.5-told with a maximum around 12 to 24 h (Fig. 1 A). 
Similar results were obtained using the phosphodieste- 
rase inhibitor IBMX. The CCK mRNA level rose -2.3- 
fold after 12 h. The drug combination of PMA and 
IBMX had a small additive effect and elevated the CCK 
mRNA level -6.5fold, compared to controls (no 
drugs). In PMA-treated cells, it appeared that the 
elevated CCK mRNA lcvcl did not change significantly 
between 12-24 h. whereas in IBMX-. or PMA- and 
146 
A 
Relalive CCK mRNA l~el 
25 I 
20 
4 8 12 
hours 
B 
Relative c-foe mRNA level 
25 
20 
16 
10 
5 
0 
24 
24 
4 1D.A 3 ID.8 
t actin 
CCK 
Fig. I. Time course of the effects of PMA and IBMX. alone or in 
combination on the CCK (A) and c:/bs tnRNA (B) abundance in 
SK-N-MC cells. Cultures ol’SK-N-MC cells wcrc trcatcd with 0.5pM 
PMA and/or 0.5 mM IBMX for the times indicated. The mRNA 
abundances arc exprcsscd as ratios IO the control Icvcl at zero times 
(no drug). Each lane rcceivcd I5 pg total RNA and autoradiograms 
were dcrivcd from successive hybridization of the same Northern blot 
(C). Histograms rcprcscnt Ihc mean dcnsitomctric VBIUCS obtained 
from two cxpcritncnts. (Con. control. I)V drugs: I. IBMX: P, PMA!. 
IBMX-treated cells, a slight decrcasc of the CCK 
mRNA levels was observed (Fig. IA). 
Under the cxpctimcntal conditions described. the c- 
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Fig. 2. Schematic illustration of the conserved G/OS -292 element (a). 
present in the human CCK (b), rat CCK (c). and human PEA (d) 
enhancers. Italics in (b) and (d) indicate base differences. fro/is-Acting 
factors. identified by DNA binding assays [I.221 are cross-hatched. 
SOS mRNA level increased ~4 to 6-fold but with an 
apparently different time course. In cells treated with 
PMA or IBMX, the c-fos mRNA content elevated ~4 
times after 4 h and remained at this level. The combina- 
tion of PMA and IBMX showed a synergistic effect on 
c-fis mRNA expression. After 4 h of treatment with 
PMA and IBMX the c-fos mRNA level increased -10 
times. A further increase of C--OS mRNA was observed 
after 12 h, where it reached its maximum expression 
(-20 times above controls), which then gradually fell 
back to the control level after 24 h (Fig. 1 B). Obviously, 
the combination PMA and IBMX had its maximal sy- 
nergistic effect on C-SOS mRNA expression at 8-12 h 
treatment. These findings were confilmed by a different 
set of experiments. In three different experiments. SK- 
N-MC cells were treated for 10 h with PMA (0.5 PM). 
IBMX (0.5 mM) or PMA and IBMX in combination. 
PMA increased CCK mRNA 3.18 t 0.70 and c-fis 
mRNA 3.31 + 0.63 (SEM; II = 3)-fold that of controls. 
Similar results were obtained with IBMX. where CCK 
mRNA increased 2.65 It 0.38 and c$os mRNA 3.13 t- 
0.37 (SEM: rt=3)-fold as compared to the controls. The 
synergistic effect of the combination PMA and IBMX 
on c-fos mRNA or the additive effect of the drug com- 
bination on CCK mRNA modulation as observed dur- 
ing the time course was confirmed. The CCK mRNA 
content increased 5.38 t 0.35.fold and the c-j& mRNA 
13.09 2 1.68 (SEM: rr=3)-fold. In previous experiments 
we were able to show that noradrenaline and dbcAMP 
increased the level of CCK mRNA to a maximum of 
~1.5-2.5 times that of controls between 9 and 18 h [18]. 
which is in agreement with the results of the present 
study using IBMX. 
4. DISCUSSION 
Rcccnt studies of the human ncuroblastoma ccl1 Zinc 
SK-N-MC have rcvcalcd that expression of the CCK 
gene is modulated by a CAMP dependent mechanism at 
the mRNA level [ 18.211. Using deletion mutation analy- 
sis and DNA footprinting it was recently shown that the 
rat CCK promoter/enhancer, located distally to the 
mRNA initiation (CAP) site, contains phorbol ester 
(TRE) and CAMP response elements (CRE) [22]. 
Phorbol esters exert its effects by activating protein 
kinase C, which may directly effect gene activity, 
whereas IBMX is capable of inhibiting CAMP 
phosphodiesterase activities [5,25] and thereby elevating 
intracellular CAMP levels. 
Surprisingly. it was found that the DNA sequence of 
the rat and human CCK promoter region between - 119 
and -81 are not only highly conserved but also contain 
an identical 5’-CTGCGTCAGC-3’ element. present 
within the c-fos -296 element [22], known to be impor- 
tant for the transcriptional regulation of the c-fos gene 
[ 10.1 I]. Moreover. the responsive lement S-CTGCGT- 
CAGC-3’. found in the rat and human CCK gene at 
-85, is also identical to the human proenkephalin A 
(ENKCRE-2) element (Fig. 2). which has been shown 
to bind a variety of transcription factors [3.6] such as 
AP-1, AP-4, and CREB. which are inducible by PMA. 
CAMP. or both. This study shows that in SK-N-MC 
cells not only c$obs mRNA but also the CCK mRNA 
abundance is modulated by PMA, IBMX, or the drug 
combination. However, their mRNA levels appear to be 
differently regulated by the drugs used in this study 
(Fig. 1). This suggests that in human SK-N-MC cells, 
phorbolester and CAMP inducible transcription factors 
may bind to similar putative TRE and CRE DNA se- 
quences present in both the human CCK and c-SOS 
genes. We therefore conclude that the elevated CCK 
and c-jos mRNA levels may be due to increased tran- 
scription of the CCK and c-j& genes. However, it can 
not be excluded that changes in mRNA stability also 
contribute to the change in CCK and c$os mRNA 
levels. 
From the data it also appears that the c-fos mRNA 
increase precedes the elevation of CCK mRNA (Fig. I ). 
Previous studies revealed that c$os mRNA expression 
in the spinal cord after peripheral inflammation and in 
the hippocampus after seizure [26-281 precedes the in- 
crease of proenkephalin A (PEA) and prodynorfin 
(DYN) mRNA. respectively. Findings, which led to the 
conclusion that the PEA and the DYN genes may be a 
target for the fos_jrrrtlAP-I complex, which binds to an 
AP-1 DNA motif. thereby modulating basal and enhan- 
ced PEA and DYN mRNA expression [9,26,28]. Based 
on these observations and the fact that the CCK and 
PEA gents share structurally related regulatory cle- 
ments [1,18,22] and Fig. 2) it cannot be excluded that 
the C$J.S gene product may act in concert withj[rrrlAP-1 
[29.30] on the putative AP-I response element. and the- 
rcby modulating CCK mRNA expression. Altcrnati- 
vely. c~fu.s may activate CCK mRNA expression in an 
indirect way by inducing transcription of ccl1 spccifk 
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transcription factor(s). necessary for the elevated CCK 
mRNA expression described in this study. 
In conclusion, it appears that maximal activation of 
both the PKC and PKA pathways in SK-N-MC cells 
may subsequently lead to the induction of basal and cell 
specific CCK and c-j&s transcription factors, which 
bind to putative TRE and CRE elements, thereby mo- 
dulating a co-ordinate but differential expressin of CCK 
and c-j& mRNA in the human neuroblastoma ceil line 
SK-N-MC. Experiments to establish the nature of the 
transcription factor(s) and the DNA binding sites. in- 
vo!ved in the modulation of CCK mRNA expression, 
are in progress in our laboratory. 
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